Apostoae F, Tarţău Liliana, Cimpoeşu Diana, Lupuşoru Cătălina Elena
Universităţii de Medicină şi Farmacie "Gr. T. Popa" Iaşi.
Rev Med Chir Soc Med Nat Iasi. 2011 Oct-Dec;115(4):1155-61.
To evaluate drugs interactions with oral anticoagulants and their clinical relevance, in patients from two emergency departments in hospital.
Retrospective study, during one year, on patients (between 18 and 85 year old) with haemostatic disturbances admitted at two emergency departments in ,,Sf. Spiridon" Hospital, Iaşi and in Piatra Neamţ Public Hospital, consisted in medical records analysis: the diagnostic, therapy recommended. Data were scored and statistically analyzed by t test (Windows Excel). The experimental protocol was in agreement with recommendations of the "Gr. T. Popa" University Committee for Research and Ethical Issues.
Analysis and statistical processing of data shows that during the period of the study, 69 patients, which received oral anticoagulant therapy associated with different other medication belonged to the 60 and 80 years age group. The findings suggests the pathology is represented especially by atrial fibrillation and cerebral ischemic diseases. The correlation between the therapy consisting in OAC and amiodaronum or statines drugs association and International Normalized Ratio (INR), revealed a high level of anticoagulation and an increase of hemorragic complications.
评估医院两个急诊科患者中药物与口服抗凝剂的相互作用及其临床相关性。
对“圣斯皮里东”医院雅西分院和皮亚特拉尼亚姆茨公立医院两个急诊科收治的(年龄在18至85岁之间)有止血障碍的患者进行为期一年的回顾性研究,包括病历分析:诊断、推荐治疗方法。数据进行评分并通过t检验(Windows Excel)进行统计分析。实验方案符合“格·T·波帕”大学研究与伦理问题委员会的建议。
数据的分析和统计处理表明,在研究期间,69例接受口服抗凝剂治疗并同时使用其他不同药物的患者年龄在60至80岁之间。研究结果表明,病理情况主要表现为房颤和脑缺血性疾病。口服抗凝剂(OAC)与胺碘酮或他汀类药物联合治疗与国际标准化比值(INR)之间的相关性显示出抗凝水平较高且出血并发症增加。